ENDRA Life Sciences (NDRA) Debt to Equity (2020 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Debt to Equity for 2 consecutive years, with $0.04 as the latest value for Q3 2021.
- Quarterly Debt to Equity fell 56.28% to $0.04 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $0.04 through Sep 2021, down 56.28% year-over-year, with the annual reading at $0.05 for FY2020, N/A changed from the prior year.
- Debt to Equity for Q3 2021 was $0.04 at ENDRA Life Sciences, up from $0.0 in the prior quarter.
- The five-year high for Debt to Equity was $0.35 in Q2 2020, with the low at $0.0 in Q1 2021.